Anurag S Rathore

Title: Anurag S Rathore: Innovator in Recombinant Methods

Introduction

Anurag S Rathore is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant methods for producing polypeptides. With a total of 2 patents to his name, Rathore's work has the potential to impact the pharmaceutical industry significantly.

Latest Patents

Rathore's latest patents include a method for the preparation of growth hormone and its antagonist with reduced levels of isoform impurities. This invention focuses on recombinant methods that yield a polypeptide product containing fewer isoform impurities. Specifically, it addresses the reduction of trisulfide and des-phe isoform impurities in growth hormone and its antagonist, such as pegvisomant. Another notable patent is a process for decreasing aggregate levels of pegylated protein, which also utilizes recombinant methods to produce desired pegylated isoforms with reduced aggregate levels.

Career Highlights

Anurag S Rathore is currently employed at Pfizer Corporation, where he continues to innovate and contribute to the field of biotechnology. His work at Pfizer has allowed him to collaborate with leading experts in the industry, further enhancing his research and development efforts.

Collaborations

Rathore has worked alongside notable colleagues, including Denis M Boyle and John J Buckley. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared goals in biotechnology.

Conclusion

Anurag S Rathore is a distinguished inventor whose work in recombinant methods has the potential to revolutionize the production of important biopharmaceuticals. His contributions to the field are noteworthy, and his ongoing efforts at Pfizer Corporation continue to push the boundaries of innovation.